יחס שווי פעילות לרווח לפני ריבית, מסים ופחת Modular Med (MODD)
Modular Medical (MODD) is currently transitioning to active sales of available MOD-1 pumps, focusing on FDA approval and pharmacy partnerships. The company's revenues are based on the sale of wearable devices for blood sugar monitoring for patients with diabetes. This daily price action reflecting the evolution of quotes confirms its status as a diabetes-tech innovator with a metric at 0.00, cementing the brand's leadership potential in the field of simplified electronics.
פילוחי מדדים מקיפים ואנליטיקה עבור modular-medical.com (MODD)
Market optimism regarding the leadership of Modular Medical (MODD) in diabetes tech requires verification through the actual scale of capital expenditures and debt load. By analyzing the enterprise value to EBITDA multiple, an investor assesses the total business value relative to its ability to generate cash flow, which allows for the determination of the asset's fair price considering the R&D intensity of insulin pump development.
